Departments of Biophysics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8816, USA.
ACS Chem Biol. 2013 Mar 15;8(3):626-35. doi: 10.1021/cb300604u. Epub 2012 Dec 26.
For several well-documented reasons, it has been challenging to develop artificial small molecule inhibitors of protein/protein complexes. Such reagents are of particular interest for transcription factor complexes given links between their misregulation and disease. Here we report parallel approaches to identify regulators of a hypoxia signaling transcription factor complex, involving the ARNT subunit of the HIF (Hypoxia Inducible Factor) activator and the TACC3 (Transforming Acidic Coiled Coil Containing Protein 3) coactivator. In one route, we used in vitro NMR and biochemical screening to identify small molecules that selectively bind within the ARNT PAS (Per-ARNT-Sim) domain that recruits TACC3, identifying KG-548 as an ARNT/TACC3 disruptor. A parallel, cell-based screening approach previously implicated the small molecule KHS101 as an inhibitor of TACC3 signaling. Here, we show that KHS101 works indirectly on HIF complex formation by destabilizing both TACC3 and the HIF component HIF-1α. Overall, our data identify small molecule regulators for this important complex and highlight the utility of pursuing parallel strategies to develop protein/protein inhibitors.
由于几个有充分文献记录的原因,开发蛋白质/蛋白质复合物的人工小分子抑制剂一直具有挑战性。鉴于转录因子复合物的失调与疾病之间存在关联,此类试剂对于转录因子复合物特别有研究意义。在这里,我们报告了平行的方法来鉴定缺氧信号转导转录因子复合物的调节剂,该复合物涉及 HIF(缺氧诱导因子)激活物的 ARNT 亚基和 TACC3(转化酸性卷曲螺旋蛋白 3)共激活因子。在一种途径中,我们使用体外 NMR 和生化筛选来鉴定选择性结合在招募 TACC3 的 ARNT PAS(Per-ARNT-Sim)结构域内的小分子,鉴定 KG-548 为 ARNT/TACC3 破坏剂。一种平行的、基于细胞的筛选方法先前表明小分子 KHS101 是 TACC3 信号的抑制剂。在这里,我们表明 KHS101 通过使 TACC3 和 HIF 成分 HIF-1α 失稳来间接作用于 HIF 复合物的形成。总的来说,我们的数据为这个重要的复合物鉴定了小分子调节剂,并强调了采用平行策略开发蛋白质/蛋白质抑制剂的实用性。